
UCL accelerates research of relapse in childhood blood cancer
The University College London (UCL) has entered into a partnership with ViroCell Biologics to advance Professor Persis Amrolia’s innovative chimeric antigen receptor (CAR) T-cell therapy for relapsed paediatric acute lymphoblastic leukaemia (ALL). Dr Amrolia is Professor of Transplantation Immunology at the UCL Great Ormond Street Institute of… Read More
